Joint Formulary & PAD

Olanzapine - Parkinson's Disease (psychosis)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
BNF SPC
NFD1
Restrictions / Comments :

Documentation

PAD Profile

ChemicalSubstance :
Olanzapine
Indication :
Parkinson's Disease (psychosis)
Group Name :
Keywords :
psychotic symptoms, PD, hallucinations, delusions, psychosis in Parkinson's disease
Brand Names Include :
Zyprexa
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Olanzapine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Parkinson's Disease (psychosis).

Committee Recommendations (1)

NICE does not recommend the use of olanzapine to treat hallucinations and delusions in Parkinson's disease